HomeEXECUTIVESGraham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

Graham Belgrave, Senior Vice President of European Operations at Advanced Clinical, has been recognized by PharmaVOICE magazine as a distinguished leader on the 2021 PharmaVOICE 100 list.

 

As one of the first European hires at Advanced Clinical in 2017, Graham Belgrave built the company’s infrastructure and functional teams outside of North America, contributing to the company’s fast growth and development in regions outside of North America. Under his leadership, Advanced Clinical has grown tremendously from having minimal presence in Europe to now having 10 country offices and a European team comprised of tenured and experienced industry professionals that are dedicated to serving clients.

 

“The amazingly powerful culture of servant leadership that permeates through Advanced Clinical is, in my opinion of 37 years in the pharmaceutical industry, truly unique,” said Belgrave. “It empowers, supports, and inspires in equal measure. I am fortunate to be in a position to fully embrace and live this ‘way of working’ and am humbled to be awarded this honor, surrounded as I am by such a stellar group of leaders.”

At Advanced Clinical, and from previous organizations, Belgrave serves as a mentor to several colleagues, where he challenges them to think outside of the box and take risks. From past leadership accomplishments to serving as a member of several scientific and pharmaceutical associations, Belgrave is most proud of his collaborations with his team and helping them to develop their skillsets.

PharmaVOICE 100 is an annual list established by PharmaVOICE magazine that recognizes individuals whose inspiration, motivation, and outstanding leadership have made an impact to the life sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers and are selected based on specific criteria as well as involvement in community and philanthropic efforts. The honorees represent a broad cross-section of industry leaders.

The July/August special issue of PharmaVOICE magazine is available for viewing online. To learn more about Belgrave’s leadership and accomplishments, please visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy